X
Jun 08, 2022 05:54 PM (GMT+8) · EqualOcean
Borui pharmaceutical announced that the company plans to sign the equity transfer agreement with Suzhou Hongbo to transfer the 2.42% equity of caike biology held by the company to Suzhou Hongbo for a consideration of 20million yuan. After the transfer, the company will still hold 7.19% of the shares of caike biology.